about
Laparoscopic gastric cancer surgery: Current evidence and future perspectivesMinimally invasive surgery for gastric cancer treatment: current status and future perspectives.Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancerNew surgical approach for gastric bezoar: "hybrid access surgery" combined intragastric and single port surgeryAssociation between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study.Oncologic Safety of Laparoscopic Wedge Resection with Gastrotomy for Gastric Gastrointestinal Stromal Tumor: Comparison with Conventional Laparoscopic Wedge Resection.Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.Robotic gastrectomy for gastric cancer.Long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy.Surgical Outcomes After Open, Laparoscopic, and Robotic Gastrectomy for Gastric Cancer.Status and Prospects of Robotic Gastrectomy for Gastric Cancer: Our Experience and a Review of the LiteratureRobotic D2 Lymph Node Dissection During Distal Subtotal Gastrectomy for Gastric Cancer: Toward Procedural Standardization.A Novel Prediction Model of Prognosis After Gastrectomy for Gastric Carcinoma: Development and Validation Using Asian Databases.Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.Hybrid Natural Orifice Transluminal Endoscopic Surgery with Sentinel Lymph Node Navigation for Deep Early Gastric Cancer in the Fundic Region.Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion.Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.Advanced real-time multi-display educational system (ARMES): An innovative real-time audiovisual mentoring tool for complex robotic surgery.Consideration of clinicopathologic features improves patient stratification for multimodal treatment of gastric cancer.Impact of splenic hilar lymph node metastasis on prognosis in patients with advanced gastric cancer.Improved glycemic control with proximal intestinal bypass and weight loss following gastrectomy in non-obese diabetic gastric cancer patients.Comparison of the effects of patient-controlled epidural and intravenous analgesia on postoperative bowel function after laparoscopic gastrectomy: a prospective randomized study.Western Validation of a Novel Gastric Cancer Prognosis Prediction Model in US Gastric Cancer Patients.A case of gastric cancer metastasis to the breast in a female with BRCA2 germline mutation and literature review.Robotic gastrectomy for elderly gastric cancer patients: comparisons with robotic gastrectomy in younger patients and laparoscopic gastrectomy in the elderly.Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial.Extent of Mediastinal Lymphadenectomy and Survival in Superficial Esophageal Squamous Cell Carcinoma.Comparison of the outcomes of laparoscopic and open approaches in the treatment of periappendiceal abscess diagnosed by radiologic investigation.Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm.Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical TrialMultidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapySingle Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC TrialTen Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master SurgeonPrognostic Impact of Extended Lymph Node Dissection versus Limited Lymph Node Dissection on pN0 Proximal Advanced Gastric Cancer: a Propensity Score Matching Analysis.Similar Operative Outcomes between the da Vinci Xi® and da Vinci Si® Systems in Robotic Gastrectomy for Gastric Cancer.A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy.Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrenceClinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancerMethod of reconstruction governs iron metabolism after gastrectomy for patients with gastric cancer
P50
Q26774648-03AE5CC8-DDBC-4CE2-A265-99BBFC934276Q33633632-E752E125-B3C4-4203-825A-A5CD3F36F236Q33888813-0FBA7437-8FB6-4314-8BF9-74CF866B43C3Q35740367-6999D1FE-BCB1-4046-8B8C-10BE65AB0443Q36490577-5C4B3D6F-5639-4AEB-8FB5-3DD51D2D3FF6Q36490582-1EF06DB6-2564-4693-B71B-E5E5E7468431Q37536970-B1026469-1966-4381-9AC4-5B9B7AA59720Q38510894-34059D4A-3D06-4C67-8710-F3A8341DCE34Q38714550-415231CC-3957-4FD9-B336-4098EA7C4D65Q38867769-02BD5E7B-C772-41BD-92F0-6CF81A808DC4Q39381671-12BBFCFD-D989-4553-A71A-4ACB7EBE9A39Q39936899-4AFEB28A-E7B0-42AA-9B7B-083E6C2BE8FEQ39946440-717991B7-7180-4288-8798-720277862B4CQ40407857-827DD815-A959-48E1-9497-971E701A8C66Q41847216-FA2B0106-3134-438F-BA8C-B94BAF52A515Q43524563-F6633F1F-0A4C-4AF8-BA44-279E843AE88AQ45753281-84F8B8FE-9091-46AA-A9E5-37675EE9800CQ46525121-6613574F-7531-4F86-A63E-4131F945DE5DQ47099962-1C8C1EB7-6F9C-456A-9FFA-29D6CEC492FDQ47143606-BB3D9C1D-21D0-4266-AB4C-E56A34494FDFQ47173393-228CDEB1-CFDF-4631-852C-17B84341AF93Q47309963-918CFB91-4E91-41E9-8B6E-4830B5E9C754Q47562091-494F1130-048B-4F3E-B5CD-B5C31289B100Q47569586-8AF50B82-E4BF-4895-99DA-70E6D16C97E9Q48108613-B4C200C2-7796-4E8A-B29A-CFF2C819D949Q48151795-8F6B03C9-8419-4A5B-AF12-2227E904464FQ48230985-0CA4EC63-A70A-4C7B-9867-7459414C3026Q52764693-25463AAE-60D2-4A30-A36D-D39354023C0EQ53255254-BF6F7512-2F05-4B8C-BBD2-862CF1935344Q55437773-B7E0F5CE-49FF-4853-9117-B3036DF476C9Q57068038-B3AA9725-9090-4B43-A7C5-DBF244290CE2Q59330587-05307B7B-3C1D-4DB3-A9A0-C8D95B5F1649Q61447416-A536091E-B2C1-4383-8C43-26BEBFD04634Q64230121-1D5F0F7D-C899-4829-9208-00F599F0A36EQ64943593-5665018F-ECE2-4839-9A40-6E76148050EFQ64964941-0CD8DB71-8A17-467A-BC59-2586A5DCEF6CQ64965019-351CC6B1-DE5C-4344-94DF-4148C16930F2Q82184124-8B36C81F-7D85-4645-A222-8005C12FFD4BQ83641103-F917F18B-00E5-4DAC-A498-38F02C5213DCQ85906309-4A17988D-D11E-4577-B1E0-42449E3D7850
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Taeil Son
@ast
Taeil Son
@en
Taeil Son
@es
Taeil Son
@nl
Taeil Son
@sl
type
label
Taeil Son
@ast
Taeil Son
@en
Taeil Son
@es
Taeil Son
@nl
Taeil Son
@sl
prefLabel
Taeil Son
@ast
Taeil Son
@en
Taeil Son
@es
Taeil Son
@nl
Taeil Son
@sl
P106
P1153
55390370300
P31
P496
0000-0002-0327-5224